Loading clinical trials...
Loading clinical trials...
Glucose as a Mediator of Self-control Performances in Patients With Schizophrenia: A Randomized Controlled Study
The research aims to investigate the relationship between self-control ability and blood glucose level in schizophrenic patients. The main purpose of the present study is to explore whether the close relationship of blood glucose and self-regulatory strength observed in healthy individuals, is applicable to schizophrenic patients. More specifically, the current study aims * to investigate whether the exertion of self-control reduces blood glucose, * to examine whether low level of blood glucose deteriorates subsequent self-control performances * to examine whether restoring the glucose level eliminates these impairments, in schizophrenic patients.
Age
15 - No limit years
Sex
ALL
Healthy Volunteers
No
The University of Hong Kong
Hong Kong, China
Start Date
April 1, 2012
Primary Completion Date
April 1, 2013
Completion Date
April 1, 2013
Last Updated
March 26, 2012
100
ESTIMATED participants
glucose drink
DIETARY_SUPPLEMENT
Lead Sponsor
The University of Hong Kong
Collaborators
NCT07455929
NCT06740383
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions